SCHEMBL2657604

SCHEMBL2657604

COc1ccc(Cl)c(-c2cc(-n3cnc4cc(C(C)(C)O)ccc43)ccc2F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 5/20 0.50
FGFR1 P11362 4/20 0.45
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 1/20 0.43
GSK3B P49841 1/20 0.40
KDR P35968 1/20 0.39
HPGD P15428 6/20 0.39
THRB P10828 1/20 0.39
MAPK1 P28482 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 2/20 0.38
MAPK10 P53779 1/20 0.37
NCOA1 Q15788 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2657910 0.85 GABRA1 (0.57) GABRA1FGFR1GABRG2GABRB3GABRA5
SCHEMBL2659150 0.82 GABRA1 (0.53) GABRA1FGFR1GABRG2GABRB3GABRA5
SCHEMBL2656721 0.81 GABRA1 (0.52) GABRA1FGFR1GABRG2GABRB3GABRA5
SCHEMBL2335595 0.81 GABRA1 (0.67) GABRA1FGFR1GABRG2GABRB3GABRA5
SCHEMBL2337133 0.80 GABRA1 (0.73) GABRA1FGFR1GABRG2GABRB3GABRA5
SCHEMBL2336126 0.80 GABRA1 (0.72) GABRA1FGFR1GABRG2GABRB3GABRA5
SCHEMBL2338310 0.80 GABRA1 (0.61) GABRA1FGFR1GABRG2GABRB3GABRA5
SCHEMBL2334885 0.79 GABRA1 (0.53) GABRA1FGFR1GABRG2GABRB3GABRA5
SCHEMBL2658496 0.78 GABRA1 (0.60) GABRA1FGFR1GABRG2GABRB3GABRA5
SCHEMBL2656995 0.77 GABRA1 (0.47) GABRA1FGFR1GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010055129-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABAA RECEPTOR COMPLEX NEUROSEARCH A/S (DK) 2010-05-20 WO claimed